Fluoxetin-Mepha Dispersible 20 mg

Fluoxetin-Mepha Dispersible 20 mg is a medicine authorised by Swissmedic under authorisation number 57235. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 27 September 2005 and the authorisation is valid without a time limit. ATC code N06AB03 places the medicine in the group Psychoanaleptics.

  • Dispensing category B
  • Authorisation number 57235
  • ATC N06AB03
  • Synthetic medicines
Authorisation data
Authorisation number57235
NameFluoxetin-Mepha Dispersible 20 mg
Full nameFluoxetin-Mepha Dispersible 20 mg, Tabletten zur Herstellung einer Suspension zum Einnehmen
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN06AB03
First authorisation27 September 2005
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Fluoxetin-Mepha Dispersible 20 mg, Tabletten zur Herstellung einer Suspension zum EinnehmenB27 September 2005

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
410Tablette(n)N06AB0301.06.0.B
1030Tablette(n)N06AB0301.06.0.B
16100Tablette(n)N06AB0301.06.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Fluoxetin-Mepha Dispersible 20 mg authorised in Switzerland?

Yes. Fluoxetin-Mepha Dispersible 20 mg is authorised by Swissmedic under authorisation number 57235, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Fluoxetin-Mepha Dispersible 20 mg have?

Fluoxetin-Mepha Dispersible 20 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Fluoxetin-Mepha Dispersible 20 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com